Scientific Programme

 

Thursday, February 2, 2023

Opening                                 

Time Presentation Title Speaker
08:30-08:40
Entering the Future (Welcome to All Participants)
Rudi Dierckx
08:40-08:50 Outcomes of Focus 1 in 2018 Stefano Fanti
08:50-09:00 Opening and Objectives Daniela E. Oprea-Lager

 

Thursday, February 2, 2023

Staging of Intermediate and High Risk Prostate Cancer

Chairpersons: Anders Bjartell, Evis Sala, Stefano Fanti

Time Presentation Title Speaker
09:00-09:25
Staging Prostate Cancer: Still a Clinical Unmet Need?
Anders Bjartell
09:30-09:55
Staging Prostate Cancer: The Evolving Role of Radiology
Evis Sala
10:00-10:25
Staging Prostate Cancer: The Evolving Role of Nuclear Medicine
Stefano Fanti
11:00-11:15
Controversy: Should Molecular Imaging Fully Replace Conventional Imaging?
Roman Sosnowski
11:15-11:22
In Favour
Irene Burger
11:23-11:30
Against
Evis Sala
11:30-11:45
What Is the Evidence? 
Igle de Jong
11:45-12:00
Questions & Answers
 
12:00-13:00
Consensus on Imaging for Staging Intermediate and High Risk Prostate Cancer
Daniela E. Oprea-Lager, Stefano Fanti

 

Thursday, February 2, 2023

Imaging of Biochemical Recurrence in Prostate Cancer

Chairpersons: Jochen Walz, Valeria Panebianco, Andrei Iagaru

Time Presentation Title Speaker
14:00-14:25
Biochemical Recurrence in Prostate Cancer: Still a Clinical Unmet Need?
Jochen Walz
14:30-14:55 Biochemical Recurrence in Prostate Cancer: The Evolving Role of Diagnostic Imaging
Valeria Panebianco
15:00-15:25 Biochemical Recurrence in Prostate Cancer: The Evolving Role of Nuclear Medicine
Andrei Iagaru
16:00-16:22
Does Early Detection of Biochemical Recurrence Offer Survival Benefit?
Bertrand Tombal
16:23-16:45
Impact of Changing Clinical Management in Biochemical Recurrence Setting
Derya Tilki
16:45-17:00 Questions & Answers
17:00-18:00
Consensus on Imaging for Biochemical Recurrence of Prostate Cancer
Andrei Iagaru,
Daniela E. Oprea-Lager

 

Friday, February 3, 2023

Imaging of Advanced Prostate Cancer

Chairpersons: Karim Fizazi, Nina Tunariu, Irene Burger

Time Presentation Title Speaker
09:00-09:25
Advanced Prostate Cancer: Still a Clinical Unmet Need?
Karim Fizazi
09:30-09:55
Advanced Prostate Cancer: The Evolving Role of Radiology
Nina Tunariu
10:00-10:25
Advanced Prostate Cancer: The Evolving Role of Nuclear Medicine
Irene Burger
11:00-11:15 Controversy: Do We Need Next- Generation Imaging Modalities in Advanced Prostate Cancer?
Joe O’Sullivan
11:15-11:22 In Favour
Marnix Lam
11:23-11:30 Against
Valeria Panebianco
11:30-11:45
What Is the Evidence? 
Derya Yakar
11:45-12:00 Questions & Answers
12:00-13:00 Consensus on Imaging of Advanced Prostate Cancer
Joe O’Sullivan,
Daniela E. Oprea-Lager

 

Firday, February 3, 2023

Therapy of Advanced Prostate Cancer

Chairpersons: Silke Gillessen, Ken Herrmann, Oliver Sartor

Time Presentation Title Speaker
14:00-14:25 Advanced Prostate Cancer: Oncological Therapeutic Options
Silke Gillessen
14:30-14:55
Advanced Prostate Cancer: PSMA Theranostics Options
Ken Herrmann
15:00-15:25
Therapy of Advanced Prostate Cancer: Still a Clinical Unmet Need?
Oliver Sartor
16:00-16:15

Does PSMA Theranostics Offer (Enough) Survival Benefit in Advanced Prostate Cancer?

Maria De Santis
16:15-16:30
PSMA Theranostics – the Urologist’s Perspective
Alberto Briganti
16:30-16:45
PSMA Theranostics – the Medical Oncologist’s Perspective
Oliver Sartor
16:45-17:00 Questions & Answers
17:00-18:00 Consensus on Therapy of Advanced Prostate Cancer
Silke Gillessen,
Daniela E. Oprea-Lager

 

Saturday, February 4, 2023

Theranostics in Prostate Cancer – A New Kid on the Block

Chairpersons: Stefano Fanti, Daniela E. Oprea-Lager

Time Presentation Title Speaker
09:00-09:20
Development of Radiopharmaceuticals for Theranostics Applications
Sandra Heskamp
09:20-09:40
Alpha, Beta or Tandem Therapy: Good, Better, the Best?
Mike Sathekge
09:40-10:00 Current and Future Indications for Theranostics Applications in Prostate Cancer Marnix Lam
10:00-10:20
Radiation Dosimetry for Theranostic Applications in Prostate Cancer
Uta Eberlein
10:50-11:15
Clinical Trials on Theranostics in Prostate Cancer
Louise Emmett
11:15-11:35
Clinical Trials with New Oncologic Agents in Prostate Cancer
Karim Fizazi
11:35-11:55
Combining Theranostics with Radiotherapy: A New Direction?
Barbara Alicja Jereczek-Fossa
11:55-12:15
PET/MRI: A New Approach for Functional and Morphological Imaging?
Ken Herrmann
12:15-12:30
Consensus on ‘Relevant Factors to Build a Consensus’
all panellists (Chairpersons: Jolanta Kunikowska, Anders Bjartell)
12:30-12:50
Summary of Results and Debate with all Participants
all panellists (Chairpersons: Daniela E. Oprea-Lager, Stefano Fanti)
12:50-13:00
Future Directions & Closing Remarks
Daniela E. Oprea-Lager, Rudi Dierckx